The American Cancer Society released updated guidance on prostate cancer screening that calls for more frequent testing among certain populations. Men considered to have average risk should undergo prostate-specific antigen blood testing every two years beginning at age 50. Men in higher-risk categories, including Black men and those with a family history of prostate cancer, are advised to begin annual testing at age 45. Proponents of the updated guidelines expect that more intensive screening efforts will help identify cancers at earlier stages and ultimately reduce mortality rates among demographics disproportionately affected by the disease.
The recommendations reflect evolving scientific evidence suggesting that PSA-based screening can reduce disease-specific mortality in select patient populations. The screening method had previously fallen out of favor among medical professionals due to concerns about its specificity in detecting clinically significant cancers. Recent research findings have prompted a reconsideration of its clinical utility, leading to its reincorporation into screening recommendations.
Meanwhile, the Senate’s Health, Education, Labor and Pensions Committee faces organizational changes heading into the next year. Committee members announced plans to vote next week on the nomination of Heidi Overton to serve as commissioner of the Food and Drug Administration. Senator Bernie Sanders is expected to assume the committee chairmanship in January and pursue a focus on “Medicare for All” legislation. In a related development, Senator Rand Paul announced he will step down from his leadership position on the Senate homeland security committee to take on the role of top Republican on the health committee starting next year.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI